GeminIQ Website Logo

Viewing PETS free

Subscribe for full history, 50+ metrics, screener, watchlist...

PETMED EXPRESS INC

PETS

Companies in Retail-Drug Stores and Proprietary Stores

Subscribe to unlock 17+ years of data

Financial Statements

Values in Millions ($)
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Data beyond 3 years is for subscribers only.

Unlock 17+ years of financial data

Start 7-day free trial
Subscriber-only column
Other Liabilities Noncurrent
----------44
Convertible Preferred Stock
00000---0---
Assets
Assets Current
Inventory Finished Goods
-------2629351932
Cash And Cash Equivalents At Carrying Value
212736415550524655495362
Accounts Receivable Net Current
222222223222
Inventory Net
14121518161213-29---
Prepaid Expense And Other Assets Current
6867544469109
Prepaid Taxes
000000000101
Assets Current
4449596879687178949685105
Assets Noncurrent
Property Plant And Equipment Net
262828292928262627272727
Goodwill
00002727272727272727
Operating Lease Right Of Use Asset
111111111222
Assets Noncurrent
383941427076757576787879
Deferred Income Tax Assets Net
----05655656
Assets
8188100110149145146153170173163184
Liabilities And Stockhold…
Liabilities Current
Accounts Payable Current
212019202411172437392540
Sales And Excise Tax Payable Current
222525252524242525242527
Operating Lease Liability Current
000000000111
Contract With Customer Liability Current
111121223343
Accrued Income Taxes Current
00000--10---
Liabilities Current
525557586348495872726179
Deferred Income Tax Liabilities Net
00000---0---
Operating Lease Liability Noncurrent
000011111111
Liabilities
525557586449505973736280
Commitments And Contingencies
----------00
Preferred Stock Value
-----0000000
Stockholders Equity
Common Stock Value
000000000000
Additional Paid In Capital
201919191918181725232220
Retained Earnings Accumulated Deficit
91324326778797772777984
Stockholders Equity
293343528596969497100100104
Liabilities And Stockholders Equity
8188100110149145146153170173163184
Preferred Stock
000000--0---
Preferred Stock Par Or Stated Value Per Share
-----0.0010.0010.0010.0010.0010.0010.001
Preferred Stock Shares Authorized
-----5555555
Preferred Stock Shares Issued
-----00-0000
Preferred Stock Shares Outstanding
-----0000000
Preferred Stock Liquidation Preference
-----0000000
Series A Preferred Stock
000000--0---
Allowance For Doubtful Accounts Receivable Current
000000000000
Common Stock Par Or Stated Value Per Share
0.0010.0010.0010.0010.0010.0010.0010.0010.0010.0010.0010.001
Common Stock Shares Authorized
404040404040404040404040
Common Stock Shares Issued
212121212121212121212121
Shares Outstanding
212121212121212121212121

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Custom Table

0/5
Search a metric to start building a table

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Interactive Financial Visualizations

0/1
Search a metric to start building a visual

Subscribe to unlock 17+ years of data

Earnings Market Reaction

Fiscal Year
Q1 1 Month
Q1 2 Month
Q1 3 Month
Q2 1 Month
Q2 2 Month
Q2 3 Month
Q3 1 Month
Q3 2 Month
Q3 3 Month
Q4 1 Month
Q4 2 Month
Q4 3 Month
2026----7.78%-20.00%-27.50%-8.05%-25.17%-23.15%-17.37%-6.57%-
20250.95%16.46%22.47%-19.20%-9.95%-13.79%-20.49%-33.40%-31.31%0.78%-35.55%28.91%
2024-14.08%-16.37%-24.22%8.85%9.14%-2.18%-0.73%5.60%-5.84%-6.30%-11.14%-22.76%

Data beyond 3 years is for subscribers only.

Unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data and 50+ calculated metrics

Performance and Valuation Metrics

Metrics
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Data beyond 3 years is for subscribers only.

Unlock 17+ years of financial data

Start 7-day free trial
Subscriber-only column
Liquidity Ratios
Current Ratio
0.84
0.89
1.05
1.18
1.26
1.43
1.45
1.33
1.30
1.32
1.38
1.33
Quick Ratio
0.45
0.52
0.68
0.75
0.91
1.10
1.11
0.83
0.81
0.72
0.92
0.81
Working Capital
-8.47M
-6.26M
2.77M
10.28M
16.10M
20.42M
21.95M
19.32M
21.49M
23.15M
23.40M
26.05M
Leverage & Debt
Debt to Equity
1.81
1.68
1.33
1.13
0.75
0.51
0.51
0.63
0.76
0.73
0.62
0.77
Interest Coverage TTM
-29.32
-67.97
-72.57
-75.00
-3.55
1.94
-4.41
-4.00
-15.97
-9.44
-6.48
3.15
Debt Ratio
0.64
0.63
0.57
0.53
0.43
0.34
0.34
0.39
0.43
0.42
0.38
0.43
Efficiency & Turnover
Asset Turnover TTM
1.56
1.61
1.61
1.61
1.42
1.53
1.66
1.60
1.67
1.62
1.63
1.52
Days Sales Outstanding TTM
4.31
3.73
3.30
3.33
4.50
3.15
2.70
2.82
3.26
2.55
2.54
2.53
Receivables Turnover TTM
84.74
97.94
110.61
109.65
81.06
115.88
134.99
129.50
111.91
142.99
143.74
144.06
Per Share Metrics
Diluted EPS TTM
-2.74
-3.09
-2.63
-2.13
-0.30
0.02
-0.05
-0.12
-0.37
-0.13
-0.04
0.06
Free Cash Flow Per Share TTM
-1.58
-1.09
-0.75
-0.23
-0.02
0.04
-0.04
-0.43
-0.01
0.08
0.85
0.81
Dividend Per Share TTM
0.00
0.00
0.00
0.00
0.01
0.01
0.01
0.31
0.61
0.91
1.21
1.21
Margin Metrics
Gross Profit Margin TTM
28.05%
27.53%
29.33%
30.43%
30.46%
32.23%
31.24%
30.21%
30.16%
28.11%
27.80%
27.74%
Operating Profit Margin TTM
-32.77%
-31.56%
-24.71%
-18.90%
-0.67%
0.27%
-0.77%
-0.61%
-2.90%
-1.64%
-0.83%
0.23%
Net Profit Margin TTM
-32.00%
-34.70%
-27.75%
-20.84%
-2.76%
0.15%
-0.38%
-0.96%
-2.66%
-0.96%
-0.31%
0.50%
Growth Metrics
Net Revenue Growth (1Y)
-21.13%
-22.97%
-22.57%
-21.22%
-19.25%
-12.37%
-5.34%
1.60%
9.54%
6.92%
3.69%
0.67%
Net Income Growth (1Y)
813.51%
-18,270.59%
5,613.71%
1,616.28%
-15.98%
-113.40%
13.43%
-295.44%
-245.21%
-129.48%
-106.29%
-92.24%
EPS Growth (1Y)
799.30%
-17,947.22%
5,534.02%
1,596.26%
-16.80%
-113.26%
12.24%
-293.73%
-244.35%
-129.30%
-106.25%
-92.29%
Valuation Metrics
P/E TTM
-0.83
-1.04
-0.95
-1.56
-13.76
278.60
-78.71
-32.28
-13.09
-57.96
-246.08
207.95
P/B TTM
1.65
2.05
1.22
1.34
1.01
1.03
0.79
0.89
1.01
1.54
2.08
2.63
P/S TTM
0.27
0.36
0.26
0.33
0.38
0.41
0.30
0.31
0.35
0.56
0.77
1.03
Market Cap
47.70M
67.23M
52.43M
68.91M
86.30M
99.46M
75.80M
83.08M
97.70M
154.42M
208.93M
273.87M
Enterprise Value
26.29M
40.31M
16.33M
27.78M
31.58M
49.36M
23.75M
37.09M
42.40M
104.98M
155.45M
212.33M
Calculated Values
Free Cash Flow TTM
-33.05M
-22.96M
-15.68M
-4.76M
-395.00K
855.00K
-918.00K
-8.80M
-194.00K
1.73M
17.42M
16.55M
Net Debt
-21.41M
-26.91M
-36.10M
-41.13M
-54.72M
-50.10M
-52.05M
-45.99M
-55.30M
-49.44M
-53.47M
-61.53M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of data

Insider Transactions

2026-06-08Purchase
Owner: Matz, Zyman Stephannie, N…
Title: -
Shares: 25,000
Price/Share: $1.75
Value: $43,750.00
Shares Owned: 2,600,000
Relationship: TenPercentOwner
Ownership: Direct
2025-08-13Purchase
Owner: Silvercape, Investments L…
Title: -
Shares: 101,000
Price/Share: $3.17
Value: $320,170.00
Shares Owned: 2,579,696
Relationship: TenPercentOwner
Ownership: Direct
2025-08-01Purchase
Owner: Silvercape, Investments L…
Title: -
Shares: 118,200
Price/Share: $3.21
Value: $379,422.00
Shares Owned: 2,478,696
Relationship: TenPercentOwner
Ownership: Direct
2025-07-21Purchase
Owner: Tache, Galante Moises, Ma…
Title: -
Shares: 25,000
Price/Share: $3.50
Value: $87,500.00
Shares Owned: 2,575,000
Relationship: TenPercentOwner
Ownership: Direct
2025-07-18Purchase
Owner: Silvercape, Investments L…
Title: -
Shares: 17,565
Price/Share: $3.23
Value: $56,734.95
Shares Owned: 2,360,496
Relationship: TenPercentOwner
Ownership: Direct

Subscribe to unlock 17+ years of data

Institutional Ownership

No data available for chart
2026-03-31
27.98%
Inst. Shares: 5,853,116
Shares Outstanding: 20,921,361
2025-12-31
32.88%
Inst. Shares: 6,906,726
Shares Outstanding: 21,008,521
2025-09-30
32.97%
Inst. Shares: 6,887,787
Shares Outstanding: 20,889,124
2025-06-30
34.87%
Inst. Shares: 7,237,327
Shares Outstanding: 20,755,416
2025-03-31
37.32%
Inst. Shares: 7,687,124
Shares Outstanding: 20,596,022

PETMED EXPRESS INC (PETS) — SEC Financial Statements & Analysis

PETMED EXPRESS INC (PETS) is a retail-drug stores and proprietary stores company, incorporated in FL. PETMED EXPRESS INC trades on PETS: Nasdaq as: PETS. Based on its latest SEC filing (Form 10-Q, period ending 2026-03-31), PETMED EXPRESS INC reported a -21.13% year-over-year revenue growth, a Gross Profit Margin of 28.05% (TTM), a Debt-to-Equity ratio of 1.81x, a Price-to-Sales (P/S) ratio of 0.27x (TTM), a Price-to-Book (P/B) ratio of 1.65 (TTM), at a market cap of $47.70M. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y
-21.13%
Gross Profit Margin TTM
28.05%
Debt To Equity
1.81x
P/S TTM
0.27x
P/B TTM
1.65
Market Cap
$47.70M

Data as of 2026-03-31 · Source: SEC EDGAR

Frequently Asked Questions

What industry is PETMED EXPRESS INC in?

PETMED EXPRESS INC (PETS) operates in the Retail-Drug Stores and Proprietary Stores industry.

What is PETS's market cap?

PETMED EXPRESS INC (PETS) has a market capitalization of $47.70M as of 2026-03-31.

What exchange does PETS trade on?

PETMED EXPRESS INC (PETS) trades on the PETS: Nasdaq.

Where is PETMED EXPRESS INC incorporated?

PETMED EXPRESS INC is incorporated in FL.

Research Faster.
Invest Smarter.

PETMED EXPRESS INC (PETS) financial data sourced directly from SEC EDGAR filings — including the latest 10-K annual report, 10-Q quarterly filings, insider transactions (SEC Form 4), institutional ownership (SEC Form 13F), Earning Marker Reaction Heat Map and 50+ calculated financial metrics like Price to Earnings Ratio (P/E), Return on Equity (ROE), Debt to Equity (D/E), Free Cash Flow Per Share (FCF/S), and Return on Invested Capital (ROIC). Unlike platforms that rely on third-party data aggregators, GeminIQ parses raw SEC filings directly — delivering institutional-grade accuracy at a fraction of the cost of Bloomberg Terminal or S&P Capital IQ.